The secret heroes: SMEs as drivers of innovation
Are only start-ups innovative? Do SMEs run out of ideas? At the Swiss Innovation Forum in Basel, the Swiss Federal Institute of Intellectual Property (IPI) is hosting a breakout session on this topic.
A look at the recently published Top 100 Swiss start-ups shows that there is no lack of creative solutions in this country. The Swiss innovation heroes are not only new entrepreneurs with a Silicon Valley image; even established SMEs are overflowing with good ideas.
A world-class valve from St Gallen’s Rhine Valley
In a breakout session, Innosuisse and the IPI will showcase how an SME continues to drive cutting-edge innovation, with the example of the company VAT.
This Swiss company, from the tranquil town of Haag, St Gallen, manufactures highly specialised valves for the production of televisions, smartphones and electric cars. High-value patents play a crucial role in their innovation strategy.
Michael Zickar, Head of Corporate Research at VAT, will show during a one-hour session how SMEs continue for years to keep on the ball with innovation. With input from innovation expert Prof. Daniel Huber, visitors will also learn how they themselves can stay creative and where they can obtain support. The session will address the following three questions:
1. Drivers of innovation: Why is it also important for SMEs to drive innovation and how should they do this?
2. How to do it: Why is innovation so difficult and how can a company innovate systematically?
3. Support for my SME: Where and how do companies obtain support with their innovation strategy?
01.01.2021 | Law and policy
The sic! journal in partnership with the Helbing Lichtenhahn Verlag from 2021
The ‘Swiss’ brand is adequately protected
A new record – more than one thousand inventions under the microscope eading
11.12.2020 | Law and policy
Indonesia removes local manufacturing requirement from its patent law
Swiss Innovation Forum 2020 to be held as an online festival
08.11.2019 | Event
Symposium on Creative Approaches to Improving Access to Medicines Globally